SAFEGUARD HEALTH ENTERPRISES INC
NT 10-Q, 1998-11-13
HOSPITAL & MEDICAL SERVICE PLANS
Previous: CADIZ INC, 10-Q, 1998-11-13
Next: ENZON INC, 10-Q, 1998-11-13



<PAGE>   1
                        UNITED STATES               
             SECURITIES AND EXCHANGE COMMISSION 
                   Washington, D.C.  20549 
      
                         FORM 12b-25

                 NOTIFICATION OF LATE FILING
                                                  SEC File Number   0-12050
                                                                  ------------
(Check One):  
[ ] Form 10-K   [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-Q  [ ] Form N-SAR

    For Period Ended:            SEPTEMBER 30, 1998
                      --------------------------------------------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

    For the Transition Period Ended:
                                     -----------------------------------------

- ------------------------------------------------------------------------------
    Nothing in this form shall be construed to imply that the Commission has
                   verified any information contained herein.
- ------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

- ------------------------------------------------------------------------------

                       PART I -- REGISTRANT INFORMATION

SAFEGUARD HEALTH ENTERPRISES, INC., A  DELAWARE CORPORATION
- ------------------------------------------------------------------------------
Full Name of Registrant

NOT APPLICABLE          
- ------------------------------------------------------------------------------
Former Name if Applicable

95 ENTERPRISE
- ------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

ALISO VIEJO, CA 92656
- ------------------------------------------------------------------------------
City, State and Zip Code

                       PART II--RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rules 12b-25(b), the following
should be completed.  (Check box if appropriate)

         [ ]              (a)     The reasons described in reasonable detail in
                                  Part III of this form could not be eliminated
                                  without unreasonable effort or expense;

         [X]              (b)     The subject annual report, semi-annual
                                  report, transition report on Form 10-K, Form
                                  20-F, 11-K, Form N-SAR, or portion thereof,
                                  will be filed on or before the fifteenth
                                  calendar day following the prescribed due
                                  date; or the subject quarterly report of
                                  transition report on Form 10-Q, or portion
                                  thereof will be filed on or before the fifth
                                  calendar day following the prescribed due
                                  date; and

         [ ]              (c)     The accountant's statement or other exhibit
                                  required by Rule 12b-25(c) has been attached 
                                  if applicable.

                                    PART III
                                   NARRATIVE

     State below in reasonable detail the reasons why Form 10-K, 10-KSB, 11-K,
20-F, 10-Q, 10-QSB, N-SAR or the transition report portion thereof could not be
filed within the prescribed time period.

     Due to the complexities of various previously entered transactions of 
SafeGuard Health Enterprises, Inc. and subsidiaries (the "Company"), the 
appropriate accounting treatment of such transactions necessitate further 
analysis and review prior to finalizing the Quarterly Report on Form 10-Q for 
the quarterly period ended September 30, 1998 on behalf of the Company.
                                                 (ATTACH EXTRA SHEETS IF NEEDED)

                                                                SEC 1344 (11/91)
<PAGE>   2


PART IV--OTHER INFORMATION

(1)              Name and telephone number of person to contact in regard to
                 this notification

<TABLE>
                  <S>                                       <C>              <C>
                       THOMAS C. TEKULVE, C.P.A.               (949)             425-4130
                 ---------------------------------------    -----------      ------------------
                         Vice President & CEO               (Area Code)      (Telephone Number)
</TABLE>

(2)              Have all other periodic reports required under Section 13 or
                 15(d) of the Securities Exchange Act of 1934 or Section 30 of
                 the Investment Company Act of 1940 during the preceding 12
                 months or for such shorter period that the registrant was
                 required to file such report(s) been filed?  If answer is no,
                 identify report(s).

                                                                 [X] Yes [ ] No
                 ------------------------------------------------

(3)              Is it anticipated that any significant change in results of
                 operations from the corresponding period for the last fiscal
                 year will be reflected by the earnings statements to be
                 included in the subject report or portion thereof?

                                                                 [ ] Yes [X] No

                 If so, attach an explanation of the anticipated change, both
                 narratively and quantitatively, and, if appropriate, state the
                 reasons why a reasonable estimate of the results cannot be
                 made.

                                 NOT APPLICABLE
- ------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date      11/10/98                       By /s/ THOMAS C. TEKULVE
     ---------------------------            ----------------------------------
                                            THOMAS C. TEKULVE, CPA, 
                                            VICE PRESIDENT AND CFO

INSTRUCTION:  The form may be signed by an executive officer of the registrant
or by any other duly authorized representative.  The name and title of the
person signing the form shall be typed or printed beneath the signature.  If
the statement is signed on behalf of the registrant by an authorized
representative (other than an executive officer), evidence of the
representative's authority to sign on behalf of the registrant shall be filed
with the form.


                                   ATTENTION
- ------------------------------------------------------------------------------
           Intentional misstatements or omissions of fact constitute
                Federal Criminal Violations (See 18 U.S.C. 1001)
- ------------------------------------------------------------------------------



                              GENERAL INSTRUCTIONS

1.  This form is required by Rule 12b-25 (17 CFR 240,12b-25) of the General
    Rules and Regulations under the Securities Exchange Act of 1934.

2.  One signed original and four conformed copies of this form and amendments
    thereto must be completed and filed with the Securities and Exchange
    Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
    General Rules and Regulations under the Act. The information contained in
    or filed with the form will be made a matter of public record in the
    Commission files.

3.  A manually signed copy of the form and amendments thereto shall be filed
    with each national securities exchange on which any class of securities 
    of the registrant is registered.

4.  Amendments to the notifications must also be filed on form 12b-25 but need
    not restate information that has been correctly furnished. The form shall be
    clearly identified as an amended notification.

5.  Electronic Filers.  This form shall not be used by electronic filers unable
    to timely file a report solely due to electronic difficulties. Filers unable
    to submit a report within the time period prescribed due to difficulties in
    electronic filing should comply with either Rule 201 or Rule 202 of
    Regulation S-T or apply for an adjustment in filing date pursuant to Rule 
    13(b) of Regulation S-T.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission